Clinically, ANXA3 overexpression has been demonstrated to be correlated with the occurrence of lymph node metastasis and the clinicopathological stages of breast cancer (Zhou et al., 2017b) and lung adenocarcinoma (Liu et al., 2009). This evidence concerns the gene ANXA3 and breast carcinoma.